Furthermore, SCF E3 ubiquitin ligase β-TrCP reduces EZH2 stability and H3K27me3 occupation through mediating EZH2 ubiquitination-proteasome degradation in breast cancer cells [48]. The gene discussed is EZH2; the disease is breast cancer.